IL22RA1 and myeloid sarcoma: Such as Kebir et al., we observed colocalization of IL-22R1+ and caveolin-1+, indicating an expression of this receptor by endothelial cells [22]; but in our hands, this expression was restricted to the brain of non-MS patients and in the NAWM of one MS patient and was of limited extent.